Ras-mutated Metastatic Colorectal Cancer Clinical Trials in Canton, Ohio

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer